Liminatus Pharma, Inc. LIMNW
0.04 USD 0.00 (+0.00%)
At closeOct 28, 2026, 4:00 PM EDT
0.08 +0.04 +100.00%
After hours · Oct 28, 4:00 PM ET
0.04 Day range 0.04
0.04 52-week range 0.04
- YTD
- 0.00%
- 1 year
- 0.00%
Financial health
Altman Z-Score
-21.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.4×
FY 2021 5y median -12.5× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -1.5×
FY 2021 5y median -1.5× FY 2025
P/FCF -1.5×
FY 2021 5y median -12.0× FY 2025
EV/EBITDA -1.6×
FY 2021 5y median -14.7× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -68.9%
FY 2021 5y median -8.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 104.0%
FY 2021 5y median 11.5% FY 2025
ROIC 35.6%
FY 2021 5y median -0.9% FY 2025
ROA -1990.4%
FY 2021 5y median -27.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -2.1%
FY 2021 FY 2025
EPS (diluted) -7.5%
FY 2021 FY 2025
Free Cash Flow -221.2%
FY 2021 FY 2025
Financial Health
Current Ratio 0.0×
FY 2021 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2021 5y median 0.1× FY 2025
Debt / Equity -0.1×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2021 5y median -1.6× FY 2025
Interest Coverage -13.7×
FY 2021 5y median -13.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31